Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 4 (1995), Issue 5, Pages 364-367
http://dx.doi.org/10.1155/S0962935195000597

Lobenzarit disodium inhibits the constitutive NO–cGMP metabolic pathways. Possible involvement as an immunomodulatory drug

Center of Pharmaceutical Chemistry, Department of Pharmacology and Toxicology, Havana City POB 6990, Cuba

Copyright © 1995 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

J. Padrón, A. Rojas, L. Glaría, et al., “Lobenzarit disodium inhibits the constitutive NO–cGMP metabolic pathways. Possible involvement as an immunomodulatory drug,” Mediators of Inflammation, vol. 4, no. 5, pp. 364-367, 1995. doi:10.1155/S0962935195000597